In patients with glioma, TRAF3IP3 stimulates cell proliferation by activating the ERK signaling pathway, and high expression of TRAF3IP3 predicts a poor prognosis (24,25). This evidence concerns the gene TRAF3IP3 and central nervous system cancer.